Harding Loevner LP Genmab A/S Transaction History
Harding Loevner LP
- $17.6 Billion
- Q2 2024
A detailed history of Harding Loevner LP transactions in Genmab A/S stock. As of the latest transaction made, Harding Loevner LP holds 2,767,805 shares of GMAB stock, worth $65.6 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
2,767,805
Previous 3,294,728
15.99%
Holding current value
$65.6 Million
Previous $98.5 Million
29.42%
% of portfolio
0.4%
Previous 0.63%
Shares
15 transactions
Others Institutions Holding GMAB
# of Institutions
232Shares Held
48.5MCall Options Held
6.8KPut Options Held
27.6K-
Alliancebernstein L.P. New York, NY15.2MShares$361 Million0.14% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$120 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.23MShares$100 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$54.7 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.46MShares$34.6 Million0.06% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $15.6B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...